adalimumab
abbvie
['adalimumab']
biosimilars cost less, but do they incur in indirect costs due to less dis control or more ae? danbio study (&gt;1,300 pts w/ ia)
costs similar or decreased 9 mo after mandatory switching to ada biosimilar (gp2017 or sb5)
decrease 15% gp2017 switchers #eular23 pos0376 
MD, PhD @UofGlasgow UK. Chair of EULAR live course subcommittee. Past Co-chair @EULAR Synovitis Study Group. CrossFit athlete and Mountains lover. Views my own.